Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Advanced Malignancies × 90 days × Clear all

Phase

Status

Not yet recruiting 2 Terminated 1 Recruiting 1 Enrolling by invitation 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 34 Breast Neoplasms 27 Neoplasms 23 Neoplasm Metastasis 23 Leukemia, Myeloid, Acute 20 Melanoma 18 Prostatic Neoplasms 17 Lung Neoplasms 15 Recurrence 14 Colorectal Neoplasms 14 Squamous Cell Carcinoma of Head and Neck 12 Ovarian Neoplasms 12 Multiple Myeloma 12 Carcinoma, Renal Cell 12 Triple Negative Breast Neoplasms 11 Uterine Cervical Neoplasms 10 Brain Neoplasms 10 Myelodysplastic Syndromes 9 Carcinoma, Hepatocellular 9 Cholangiocarcinoma 8 Pancreatic Neoplasms 7 Lymphoma, Non-Hodgkin 7 Lymphoma, Large B-Cell, Diffuse 7 Lymphoma 7 Leukemia, Lymphocytic, Chronic, B-Cell 7 Stomach Neoplasms 6 Solid Tumor 6 Leukemia 6 Head and Neck Neoplasms 6 Glioblastoma 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05351697 2026-03-17

BR105-I

BioRay Pharmaceutical Co., Ltd.

Phase 1 Terminated

Advanced Malignancies

Data powered by HemOnc (CC BY 4.0) Colophon ⚡